{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T01:07:32Z","timestamp":1657933652398},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00520-017-3570-6","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T23:07:25Z","timestamp":1485299245000},"page":"1853-1858","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of recommended weight-based dosing of granulocyte-colony stimulating factors in acute leukemia and stem cell transplant patients"],"prefix":"10.1007","volume":"25","author":[{"given":"Jennifer","family":"K. Hockings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diwura","family":"K. Owolabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce E.","family":"Broyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"C. Wheelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"issue":"10","key":"3570_CR1","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258\u20132266","journal-title":"Cancer"},{"issue":"5","key":"3570_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00520-010-0816-y","volume":"18","author":"M Aapro","year":"2010","unstructured":"Aapro M, Crawford J, Kamioner D (2010) Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now? Support Care Cancer 18(5):529\u2013541","journal-title":"Support Care Cancer"},{"issue":"21","key":"3570_CR3","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","volume":"25","author":"NM Kuderer","year":"2007","unstructured":"Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25(21):3158\u20133167","journal-title":"J Clin Oncol"},{"key":"3570_CR4","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Myeloid Growth Factors. Version 1.2015. http:\/\/www.nccn.org (Accessed on September 14, 2015)."},{"issue":"28","key":"3570_CR5","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","volume":"33","author":"TJ Smith","year":"2015","unstructured":"Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO (2015) Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 33(28):3199\u20133212","journal-title":"J Clin Oncol"},{"issue":"7","key":"3570_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-121-7-199410010-00004","volume":"121","author":"DW Maher","year":"1994","unstructured":"Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffman EW, Fox RM, Morstyn G (1994) Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med 121(7):492\u2013501","journal-title":"Ann Intern Med"},{"issue":"3","key":"3570_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00006454-199403000-00006","volume":"13","author":"P Riikonen","year":"1994","unstructured":"Riikonen P, Saarinen UM, M\u00e4kipernaa A, Hovi L, Komulainen A, Pihkala J, Jalanko H (1994) Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children. Pediatr Infect Dis J 13(3):197\u2013202","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"3570_CR8","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1182\/blood.V90.12.4710","volume":"90","author":"G Heil","year":"1997","unstructured":"Heil G, Hoelzer D, Sanz MA, Lechner K, Liu Yin JA, Papa G, Noens L, Szer J, Ganser A, O'Brien C, Matcham J, Barge A (1997) A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The international acute myeloid leukemia study group. Blood 90(12):4710\u20134718","journal-title":"Blood"},{"key":"3570_CR9","unstructured":"Neupogen\u00ae (2015) [package insert]. Amgen Inc. Thousand Oaks, CA"},{"issue":"16","key":"3570_CR10","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.2146\/ajhp070489","volume":"65","author":"EJ Ip","year":"2008","unstructured":"Ip EJ, Lee-Ma A, Troxell LS, Chan J (2008) Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide. Am J Health Syst Pharm 65(16):1552\u20131555","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"3570_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ajh.24228","volume":"91","author":"S Tavitian","year":"2016","unstructured":"Tavitian S, Denis A, Vergez F, Berard E, Sarry A, Huynh A, Delabesse E, Luquet I, Huguet F, R\u00e9cher C, Bertoli S (2016) Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy. Am J Hematol 91(2):193\u2013198","journal-title":"Am J Hematol"},{"issue":"10","key":"3570_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1200\/JCO.1989.7.10.1554","volume":"7","author":"G Morstyn","year":"1989","unstructured":"Morstyn G, Campbell L, Lieschke G, Layton JE, Maher D, O'Connor M, Green M, Sheridan W, Vincent M, Alton K et al (1989) Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 7(10):1554\u20131562","journal-title":"J Clin Oncol"},{"key":"3570_CR13","unstructured":"American Cancer Society. Cancer Facts & Figures 2016. http:\/\/www.cancer.org (Accessed on December 13, 2016)."},{"issue":"12","key":"3570_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/jnci\/djr152","volume":"103","author":"AL Potosky","year":"2011","unstructured":"Potosky AL, Malin JL, Kim B, Chrischilles EA, Makgoeng SB, Howlader N, Weeks JC (2011) Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst 103(12):979\u2013982","journal-title":"J Natl Cancer Inst"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3570-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3570-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3570-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T10:39:38Z","timestamp":1601462378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3570-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3570-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]}}}